New study checks if common painkillers are safe for breastfeeding moms
NCT ID NCT01854411
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether two common pain relievers, ibuprofen and ketoprofen, enter breastmilk in significant amounts. Researchers measured drug levels in milk from 35 breastfeeding women who had been taking one of these medicines for more than 24 hours. The goal was to help mothers and doctors make safer choices about pain relief while breastfeeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
35 people
The number who actually took part.
- Start date
-
Sep 2011
- Finished
-
Nov 2014
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Lactarium, Maternal care, Consultant of Lactation
- Ages
-
18 to 49 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * breastfeeding women after the first week of delivery * breastfeeding women treated by ketoprofen or ibuprofen per os more than 24 hours * Written Informed Consent Exclusion Criteria: * breastfeeding women treated by naproxene * Curator or justice decision's
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Analgesics use during breastfeeding and concentrations in human mature milk are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
hopital Saint Antoire
Paris, 75012, France